IMMUNOHISTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF THE ESTROGEN-REGULATED PROTEIN PS2, AND ITS RELATION WITH ESTROGEN-RECEPTOR AND PROGESTERONE-RECEPTOR IN BREAST-CANCER
S. Detre et al., IMMUNOHISTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF THE ESTROGEN-REGULATED PROTEIN PS2, AND ITS RELATION WITH ESTROGEN-RECEPTOR AND PROGESTERONE-RECEPTOR IN BREAST-CANCER, Journal of Clinical Pathology, 47(3), 1994, pp. 240-244
Aims-(i) To assess the validity of an immunocytochemical technique for
detecting pS2 protein in paraffin wax embedded tissue; (ii) to provid
e further data on the relation between pS2 protein and oestrogen recep
tor (ER) and progesterone receptor (PgR). Methods-Breast cancer excisi
on biopsy specimens were obtained from 35 previously untreated patient
s. An immunoradiometric assay was compared with an immunohistochemical
method for measuring pS2 protein. ER and PgR were measured in cytosol
fractions by enzyme immunoassay and the relation between the presence
of these receptors and pS2 protein was assessed before and after subd
ivision of the women into groups of over or under 50 years of age. Res
ults-A good correlation was seen between the immunoradiometric and imm
unohistochemical methods for pS2 protein measurement (r = 0.84; p = 0.
0001). Log-transformed data showed a significant correlation between i
ncreasing values of ER and pS2 protein (r = 0.45; p = 0.006) and to a
lesser extent between pS2 protein and PgR (r = 0.38; p = 0.03). Correl
ations were also shown between pS2+ and PgR+ status (p = 0.01), and be
tween ER and PgR positivity (p 0.05; Fisher's exact test). pS2+ protei
n status was only associated with ER+ status in patients aged 50 years
or less. Conclusions-The two methods for pS2 analysis are virtually i
nterchangeable. This provides strong support for using immunohistochem
istry for pS2 in paraffin wax embedded tissue. The association with ER
positivity and pS2+ protein status only in the premenopausal patients
may be due to the higher levels of oestrogenic stimuli in that group.